COVID-19
COVID-19 Articles
COVID-19 is rushing from player to player and team to team so quickly that games already are being pushed back on the calendar. As these delays pile up, what happens if too many games are suspended?
Published:
Taiwan Liposome shares shot up on Wednesday after the firm announced that it would be able to move forward with its COVID-19 trial that uses hydroxychloroquine.
Published:
Eli Lilly shares made a handy gain on Wednesday after the company announced an update to its SARS-CoV-2 neutralizing antibody programs.
Published:
Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in conjunction with GlaxoSmithKline.
Published:
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
Published:
Corvus Pharmaceuticals shares were sharply higher on Monday after the company announced updated data from its ongoing early-stage study in patients with COVID-19.
Published:
As COVID-19 begins to spread in New York City for a second time this year, hotspots have developed in over a dozen ZIP codes.
Published:
President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of where we stand with a coronavirus vaccine.
Published:
Retailers have been hit hard during the pandemic, and many have shut their brick-and-mortar locations. However, Dick’s Sporting Goods is expanding its nationwide footprint.
Published:
Moderna and Regeneron Pharmaceuticals each announced positive news late on Tuesday about their respective COVID-19 vaccine trials.
Published:
These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that won't also have huge product lines and robust pipelines with future drug potential and...
Published:
Things aren’t looking up for Inovio Pharmaceuticals, after the FDA notified the company that it was placing a partial hold on its COVID-19 vaccine study.
Published:
By a count of confirmed COVID-19 cases relative to the total size of the population, Peru is the nation hurt the most by far.
Published:
MediciNova has announced progress in its COVID-19 vaccine prototype, which stands out from the rest as it is administered intranasally.
Published:
The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of a Phase 3 trial.
Published: